|
Week - 1
|
|
Pharmaceutical Dosage Forms: Classification and Characterization |
|
|
Week - 2
|
|
Pharmaceutical Dosage Forms: Classification and Characterization |
|
|
Week - 3
|
|
The Importance of Quality Assurance and Quality Control |
|
|
Week - 4
|
|
The Identification of active agents and excipients: Qualitative and Quantitative Analyses, Identification of Impurities and Pharmacopeiae Analyses, Importance of Quality Assurance and Quality Control, Aim, Importance, Planning and Application of Analytic Method Development |
|
|
Week - 5
|
|
The Identification of active agents and excipients: Qualitative and Quantitative Analyses, Identification of Impurities and Pharmacopeiae Analyses, Importance of Quality Assurance and Quality Control, Aim, Importance, Planning and Application of Analytic Method Development |
|
|
Week - 6
|
|
Mid-Term Examination Week |
|
|
Week - 7
|
|
Spasifications of the Final Formulations: Morphological Analyses, Particle Size, Zeta Potential, Thermal Analyses, Spectrophotometric Analyses, Chromatographic Analyses |
|
|
Week - 8
|
|
Spasifications of the Final Formulations: Morphological Analyses, Particle Size, Zeta Potential, Thermal Analyses, Spectrophotometric Analyses, Chromatographic Analyses |
|
|
Week - 9
|
|
Spasifications of the Final Formulations: Morphological Analyses, Particle Size, Zeta Potential, Thermal Analyses, Spectrophotometric Analyses, Chromatographic Analyses |
|
|
Week - 10
|
|
Investigation of Bioavailability and Bioequivalency Studies |
|
|
Week - 11
|
|
Investigation of Bioavailability and Bioequivalency Studies |
|
|
Week - 12
|
|
Evaluation of Results of the Analyses and Documentation of Final Report |
|
|
Week - 13
|
|
Evaluation of Results of the Analyses and Documentation of Final Report |
|
|
Week - 14
|
|
Final Evaluation |
|